Breast Biopsy Markers

Biopsy markers on a table in a lab setting.




    A variety of shapes and options for every modality.

    Hologic's range of biopsy site markers come in multiple shapes, gauges and lengths, empowering physicians to individualize each patient’s care. Our comprehensive selection of markers include options for use with stereotactic, ultrasound, and MRI guided biopsies. All markers come with an ergonomic and easy to use deployment device.

    Tumark® Biopsy Site Markers


    Tumark Professional Q and U markers are sandblasted nitinol, designed to provide outstanding visibility in ultrasound, and excellent visibility under mammography at deployment. In 85% of marker placements, physicians stated the ultrasound visibility was good to excellent upon deployment.2

    Intelligent Design

    Intelligent design on all six distinct, easily identifiable shapes1 provides sound tissue fixation. Non-resorbing material expands into marker shape upon deployment to improve the stability of the anchor following a breast biopsy procedure.

    Accurate Deployment

    In the initial data collection study: 91% of markers placed under ultrasound did not migrate, as measured on the post-procedure mammogram.1 In 9 out of 10 cases the marker deployed accurately in ultrasound to the intended area.1

    Single-handed Operation

    Ergonomic handle for single-handed operation. For all modalities, the deployment device includes either a sharp or blunt cannula and centimeter markings for depth orientation. In 99% of procedures completed, physicians agreed the handle was easy to use when deployed in ultrasound.1

    Tumark Marker Shapes

    Localize the biopsy site before surgery and after successful therapy with a marker designed for long-term visibility. Tumark breast biopsy marker options provide tissue fixation and visibility in ultrasound and stereotactic modalities.

    Different breast marker devices on white background

    Our Tumark Offerings


    say ultrasound visibility was good to excellent upon deployment.1


    of markers deployed accurately to the intended area.1


    agreed the device was easy to use.1

    SecurMark® Biopsy Site Marker

    Enhance follow up ultrasound visualization three to four weeks post-biopsy with bio-absorbable suture-like netting.7

    Minimize movement in the biopsy cavity with the bio-absorbable suture-like net. Mark multiple sites with five distinct bio-compatible titanium or stainless-steel permanent shapes.

    Assortment of biopsy markers on white background

    Our SecurMark Offerings

    TriMark® and CeleroMark™ Markers

    Simple. Reliable.

    Optimal for thin-breasted patients and superficial lesions. Smooth marker deployment to the biopsy site with rigid end deploy beveled tip.

    markers on white background

    A Shape for Any Case

    Chart organizing different markers
      1. Tumark® Marker Data Collection Study, 2017, DHM-06169, 3 clinicians at 3 hospitals for 90 marker placements, 2017. 2. Based on Tumark® Data Collection Study, 3 clinicians at 3 hospitals for 45 marker placements, 2017. 3. Pinkney DM, Shah BA. Prospective Comparative Study to Evaluate the Sonographic Visibility of Five Commercially Available Breast Biopsy Markers. Journal of Diagnostic Medical Sonography. 2013;29(4):151-158. doi:10.1177/8756479313486962. *45.4 % of respondence rated SecurMark high sonographic visibility after 6-weeks post procedure, 4x more than the Gel Mark UltraCor™ 4. (currently 2 in Top Hat) Yen P, Dumas S, Albert A, et al. Post-Vacuum-Assisted Stereotactic Core Biopsy Clip Displacement: A Comparison Between Commercially Available Clips and Surgical Clip. Can Assoc Radiol J. 2018 Feb;69(1):10-15. doi: 10.1016/j.carj.2017.08.004. PMID: 29458952. Devices show reduced displacement when compared to traditional metal surgical clips (28% and 27% vs 38% displacement, p = 0.001 and p = 0.0001). Visibility is dependent on surrounding tissue, experience may vary. 5. Hologic Data on File. MISC-07876, Rev 001, attachment 2. Flores-Funes 2021 (n=60), Jain 2017 (n=9), Siegmann 2009 (n=29), Wienbeck 2017 (n=3), Stahl 2021 (n=114), Rüland 2018 (n=50), Woodard 2019 (n=1). 6. Tumark® Marker Data Collection Study, 2017, DHM-06169, 3 clinicians at 3hospitals for 90 marker placements, 2017. 7. Clinical Evaluation Report, DHM-08585. Visibility is dependent on surroundingtissue, experience may vary.